Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Premera Blue Cross	5.01.590 Bruton's Kinase InhibitorsPayerPolicy · PREMERA-5-01-590-BRUTON-S-KINASE-INHIBITORS-3EF9A7F3D6	New policy
Aug 2, 2026	Premera Blue Cross	5.01.656 Drug Quantity ManagementPayerPolicy · PREMERA-5-01-656-DRUG-QUANTITY-MANAGEMENT-18D2552D99	New policy
Aug 2, 2026	Premera Blue Cross	3.01.510 Applied Behavior Analysis (ABA)PayerPolicy · PREMERA-3-01-510-APPLIED-BEHAVIOR-ANALYSIS-ABA-65CD4A6B19	New policy
Aug 2, 2026	Premera Blue Cross	7.01.602 Shoulder Arthroscopy in AdultsPayerPolicy · PREMERA-7-01-602-SHOULDER-ARTHROSCOPY-IN-ADULTS-8550C80892	New policy
Aug 2, 2026	Premera Blue Cross	2.01.544 Transurethral Water Vapor Thermal Therapy and TransurethralPayerPolicy · PREMERA-2-01-544-TRANSURETHRAL-WATER-VAPOR-THERMAL-THERAPY-AND-TRANS-1CD06BBF16	New policy
Aug 2, 2026	Premera Blue Cross	15.01.001 Allergen TestingPayerPolicy · PREMERA-15-01-001-ALLERGEN-TESTING-01B96A75EC	New policy
Aug 2, 2026	Premera Blue Cross	10.01.512 Ambulance and Medical Transport ServicesPayerPolicy · PREMERA-10-01-512-AMBULANCE-AND-MEDICAL-TRANSPORT-SERVICES-C0629BFD54	New policy
Aug 2, 2026	Premera Blue Cross	2.04.515 Plasma-based Proteomic Screening in the Management ofPayerPolicy · PREMERA-2-04-515-PLASMA-BASED-PROTEOMIC-SCREENING-IN-THE-MANAGEMENT-C5469858CA	New policy
Aug 2, 2026	Premera Blue Cross	1.01.24 Interferential Current StimulationPayerPolicy · PREMERA-1-01-24-INTERFERENTIAL-CURRENT-STIMULATION-0A5D3D0B5F	New policy
Aug 2, 2026	Premera Blue Cross	11.01.523 (effective November 6, 2026) Site of Service: DrugsPayerPolicy · PREMERA-11-01-523-EFFECTIVE-NOVEMBER-6-2026-SITE-OF-SERVICE-DRUGS-6AA791F377	New policy
Aug 2, 2026	Premera Blue Cross	8.01.55 Stem Cell Therapy for Peripheral Arterial DiseasePayerPolicy · PREMERA-8-01-55-STEM-CELL-THERAPY-FOR-PERIPHERAL-ARTERIAL-DISEASE-11FF3324E1	New policy
Aug 2, 2026	Premera Blue Cross	7.03.08 Heart/Lung TransplantPayerPolicy · PREMERA-7-03-08-HEART-LUNG-TRANSPLANT-196C9C25BD	New policy
Aug 2, 2026	Premera Blue Cross	7.03.02 Allogeneic Pancreas TransplantPayerPolicy · PREMERA-7-03-02-ALLOGENEIC-PANCREAS-TRANSPLANT-97CB01CD96	New policy
Aug 2, 2026	Premera Blue Cross	7.01.598 Prostatic Urethral LiftPayerPolicy · PREMERA-7-01-598-PROSTATIC-URETHRAL-LIFT-91904C4810	New policy
Aug 2, 2026	Premera Blue Cross	7.01.533 Reconstructive Breast Surgery/Management of Breast ImplantsPayerPolicy · PREMERA-7-01-533-RECONSTRUCTIVE-BREAST-SURGERY-MANAGEMENT-OF-BREAST-9985A26C88	New policy
Aug 2, 2026	Premera Blue Cross	7.01.142 Surgery for Groin Pain in AthletesPayerPolicy · PREMERA-7-01-142-SURGERY-FOR-GROIN-PAIN-IN-ATHLETES-CCB7F663F6	New policy
Aug 2, 2026	Premera Blue Cross	7.01.137 Magnetic Esophageal Sphincter Augmentation to TreatPayerPolicy · PREMERA-7-01-137-MAGNETIC-ESOPHAGEAL-SPHINCTER-AUGMENTATION-TO-TREAT-4278EA4272	New policy
Aug 2, 2026	Premera Blue Cross	6.01.68 Irreversible Electroporation of Tumors Located in thePayerPolicy · PREMERA-6-01-68-IRREVERSIBLE-ELECTROPORATION-OF-TUMORS-LOCATED-IN-TH-1EEE99AB35	New policy
Aug 2, 2026	Premera Blue Cross	6.01.54 Dopamine Transporter Single-Photon Emission ComputedPayerPolicy · PREMERA-6-01-54-DOPAMINE-TRANSPORTER-SINGLE-PHOTON-EMISSION-COMPUTED-6E610EBFF0	New policy
Aug 2, 2026	Premera Blue Cross	5.01.660 Inhaled CorticosteroidsPayerPolicy · PREMERA-5-01-660-INHALED-CORTICOSTEROIDS-6B42F1F9BE	New policy
Aug 2, 2026	Premera Blue Cross	7.01.147 Minimally Invasive Ablation Procedures for Morton andPayerPolicy · PREMERA-7-01-147-MINIMALLY-INVASIVE-ABLATION-PROCEDURES-FOR-MORTON-A-A55CB43678	New policy
Aug 2, 2026	Premera Blue Cross	5.01.617 Folate AntimetabolitesPayerPolicy · PREMERA-5-01-617-FOLATE-ANTIMETABOLITES-E9D5C92A97	New policy
Aug 2, 2026	Premera Blue Cross	5.01.612 Pharmacologic Treatment of CystinosisPayerPolicy · PREMERA-5-01-612-PHARMACOLOGIC-TREATMENT-OF-CYSTINOSIS-FDC256EB2F	New policy
Aug 2, 2026	Premera Blue Cross	5.01.598 Pharmacologic Treatment to Reduce Serum PhosphorusPayerPolicy · PREMERA-5-01-598-PHARMACOLOGIC-TREATMENT-TO-REDUCE-SERUM-PHOSPHORUS-59B4FA2D47	New policy
Aug 2, 2026	Premera Blue Cross	5.01.646 SGLT2 InhibitorsPayerPolicy · PREMERA-5-01-646-SGLT2-INHIBITORS-6BF5F97E90	New policy
Aug 2, 2026	Premera Blue Cross	5.01.566 Pharmacotherapy of ThrombocytopeniaPayerPolicy · PREMERA-5-01-566-PHARMACOTHERAPY-OF-THROMBOCYTOPENIA-8E337323DD	New policy
Aug 2, 2026	Premera Blue Cross	5.01.544 Prostate Cancer Targeted TherapiesPayerPolicy · PREMERA-5-01-544-PROSTATE-CANCER-TARGETED-THERAPIES-B83D99ED54	New policy
Aug 2, 2026	Premera Blue Cross	5.01.521 Pharmacologic Treatment of Neuropathy, FibromyalgiaPayerPolicy · PREMERA-5-01-521-PHARMACOLOGIC-TREATMENT-OF-NEUROPATHY-FIBROMYALGIA-7C478E07DF	New policy
Aug 2, 2026	Premera Blue Cross	5.01.519 Increlex (mecasermin); Recombinant Human Insulin-LikePayerPolicy · PREMERA-5-01-519-INCRELEX-MECASERMIN-RECOMBINANT-HUMAN-INSULIN-LIKE-CE8EEE3786	New policy
Aug 2, 2026	Premera Blue Cross	5.01.517 Use of Vascular Endothelial Growth Factor ReceptorPayerPolicy · PREMERA-5-01-517-USE-OF-VASCULAR-ENDOTHELIAL-GROWTH-FACTOR-RECEPTOR-B85B3355E6	New policy
Aug 2, 2026	Premera Blue Cross	2.01.98 Orthopedic Applications of Platelet-Rich PlasmaPayerPolicy · PREMERA-2-01-98-ORTHOPEDIC-APPLICATIONS-OF-PLATELET-RICH-PLASMA-6F05BF92E8	New policy
Aug 2, 2026	Premera Blue Cross	2.02.24 Cardiac Hemodynamic Monitoring for the Management ofPayerPolicy · PREMERA-2-02-24-CARDIAC-HEMODYNAMIC-MONITORING-FOR-THE-MANAGEMENT-OF-7D8A7689BE	New policy
Aug 2, 2026	Premera Blue Cross	11.01.523 Site of Service: Drugs and Biologic AgentsPayerPolicy · PREMERA-11-01-523-SITE-OF-SERVICE-DRUGS-AND-BIOLOGIC-AGENTS-3B69CB197F	New policy
Aug 2, 2026	Premera Blue Cross	2.04.520 Laboratory Testing Investigational ServicesPayerPolicy · PREMERA-2-04-520-LABORATORY-TESTING-INVESTIGATIONAL-SERVICES-429709DF5E	New policy
Aug 2, 2026	Premera Blue Cross	8.01.540 Cranial Electrotherapy Stimulation and Auricular ElectrostimuPayerPolicy · PREMERA-8-01-540-CRANIAL-ELECTROTHERAPY-STIMULATION-AND-AURICULAR-EL-9389766AD2	New policy
Aug 2, 2026	Premera Blue Cross	8.01.531 Hematopoietic Cell Transplantation for WaldenströmPayerPolicy · PREMERA-8-01-531-HEMATOPOIETIC-CELL-TRANSPLANTATION-FOR-WALDENSTROM-402B551AD3	New policy
Aug 2, 2026	Premera Blue Cross	7.03.511 Isolated Small Bowel TransplantPayerPolicy · PREMERA-7-03-511-ISOLATED-SMALL-BOWEL-TRANSPLANT-8BA493232B	New policy
Aug 2, 2026	Premera Blue Cross	7.03.12 Islet Transplantation for Chronic Pancreatitis and DonislecelPayerPolicy · PREMERA-7-03-12-ISLET-TRANSPLANTATION-FOR-CHRONIC-PANCREATITIS-AND-D-CF00C9B0F3	New policy
Aug 2, 2026	Premera Blue Cross	7.01.95 Radiofrequency Ablation of Miscellaneous Solid TumorsPayerPolicy · PREMERA-7-01-95-RADIOFREQUENCY-ABLATION-OF-MISCELLANEOUS-SOLID-TUMOR-433231B3A3	New policy
Aug 2, 2026	Premera Blue Cross	7.01.72 Percutaneous Intradiscal Electrothermal AnnuloplastyPayerPolicy · PREMERA-7-01-72-PERCUTANEOUS-INTRADISCAL-ELECTROTHERMAL-ANNULOPLASTY-AE8163A447	New policy
Aug 2, 2026	Premera Blue Cross	7.01.592 Surgical Treatment of Femoroacetabular ImpingementPayerPolicy · PREMERA-7-01-592-SURGICAL-TREATMENT-OF-FEMOROACETABULAR-IMPINGEMENT-E1AB75B29C	New policy
Aug 2, 2026	Premera Blue Cross	7.01.567 Surgical Treatments for Lymphedema and LipedemaPayerPolicy · PREMERA-7-01-567-SURGICAL-TREATMENTS-FOR-LYMPHEDEMA-AND-LIPEDEMA-43599DD7A2	New policy
Aug 2, 2026	Premera Blue Cross	7.01.159 Sphenopalatine Ganglion Block for HeadachePayerPolicy · PREMERA-7-01-159-SPHENOPALATINE-GANGLION-BLOCK-FOR-HEADACHE-7F570AF6CF	New policy
Aug 2, 2026	Premera Blue Cross	7.01.153 Adipose-Derived Stem Cells in Autologous Fat GraftingPayerPolicy · PREMERA-7-01-153-ADIPOSE-DERIVED-STEM-CELLS-IN-AUTOLOGOUS-FAT-GRAFTI-FA0E8E9141	New policy
Aug 2, 2026	Premera Blue Cross	7.01.134 Steroid-Eluting Sinus Stents and ImplantsPayerPolicy · PREMERA-7-01-134-STEROID-ELUTING-SINUS-STENTS-AND-IMPLANTS-22C6592749	New policy
Aug 2, 2026	Premera Blue Cross	6.01.528 Whole Body Dual X-Ray Absorptiometry and BioelectricalPayerPolicy · PREMERA-6-01-528-WHOLE-BODY-DUAL-X-RAY-ABSORPTIOMETRY-AND-BIOELECTRI-C7A6FFB2F1	New policy
Aug 2, 2026	Premera Blue Cross	6.01.525 Therapeutic Radiopharmaceuticals in OncologyPayerPolicy · PREMERA-6-01-525-THERAPEUTIC-RADIOPHARMACEUTICALS-IN-ONCOLOGY-EE86F824CB	New policy
Aug 2, 2026	Premera Blue Cross	7.01.565 Ablation of Peripheral Nerves to Treat PainPayerPolicy · PREMERA-7-01-565-ABLATION-OF-PERIPHERAL-NERVES-TO-TREAT-PAIN-79ED8FB0CC	New policy
Aug 2, 2026	Premera Blue Cross	5.01.613 Oral Iron Chelating AgentsPayerPolicy · PREMERA-5-01-613-ORAL-IRON-CHELATING-AGENTS-AD1C883AD6	New policy
Aug 2, 2026	Premera Blue Cross	5.01.609 Spravato (esketamine) Nasal SprayPayerPolicy · PREMERA-5-01-609-SPRAVATO-ESKETAMINE-NASAL-SPRAY-E91318B967	New policy